… We analyzed 102 patients with CAD treated with CABG, who underwent re… CABG to re-CA
was 5,97±4,27 years (minimum one, maximum seventeen years). Mean age of the patients …

… of graft failure varies with the type of conduits used for CABG. … with potent paracrine effects,
such as platelet-derived growth … coronary artery disease is more associated with lower graft …

… CABG or PCI and is even more common than the progression of native coronary artery disease
in patients whom underwent CABG. … most potent and they strongly contracts arterial grafts …

… repeated procedures than did patients undergoing CABG. … from patients chosen for CABG:
Most patients treated with PCI … artery bypass grafting for coronary artery disease. Comparative …

… platelet function after CABG helps maintain graft patency and … found to be a more potent
CAD risk factor than high LDL. … the broad range of factors affecting cardiovascular outcomes, …

… specific groups of patients with coronary artery disease. Most … Factors influencing RA
performance include a greater … endovascular serotonin infusion, a potent vasoconstrictor, and had …

… Treatment with antiplatelet agents decreases the vein graft … Coronary artery disease accounts
for many patient visits to internists. Many of these patients now have bypass grafts. After a …

… as a potent risk factor for adverse outcome after CABG, … on the effect of treatments on patients
with kidney disease [52]. … effect of RAS inhibitor treatment in patients with CAD has been …

… strategy in patients with severe coronary artery disease. … Patients undergoing CABG surgery
have been reported to have … UTXB 2, as potent novel independent risk factors for early SVG …

… in patients with severe LV dysfunction undergoing CABG. … Coronary artery disease is the
most common cause of heart … as a potent risk factor for mortality following CABG; therefore, …